However, in patients without type 2 diabetes, GLP-1 agonists had no significant effect on weight loss (SMD -0.97, <i>p</i> = 0.12) or improvement in fibrosis (RR 1.54, <i>p</i> = 0.24). This evidence concerns the gene GCG and type 2 diabetes mellitus.